Akumin® is a health care startup that offers comprehensive radiation therapy solutions for various types of cancer, including brain, breast, colorectal, liver, metastatic, and skin cancers. The Cancer Treatment Center of Hazleton, headquartered in the United States, provides a range of radiation therapies such as external beam radiation therapy, intensity-modulated radiation therapy, 3-D conformal therapy, image-guided radiation therapy, and brachytherapy. They specialize in treating various types of cancer, including brain tumors, breast cancer, colorectal cancer, liver cancer, metastatic cancer, and skin cancer. Overall, Akumin® presents a promising opportunity for venture capital investment in the healthcare industry, particularly in the field of cancer treatment. With its comprehensive approach to radiation therapy and varied treatment offerings, it demonstrates a strong potential for positive impact in the oncology space. Nevertheless, more information is needed regarding its founding date and investors, and transparency in these areas will be crucial for evaluating its potential for investment.
There is no investment information
No recent news or press coverage available for Akumin®.